Iovance BiotherapeuticsIOVA +1.07%44 Days Inventory is 118.15 as of Mar. 2026, which is 2% below its 10-year median of 121.13. GuruFocus rates IOVA with a GF Score™ of 44/100 and a GF Value™ of $18.84 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 640 Biotechnology companies, Iovance Biotherapeutics ranks better than 68.91% on this metric.
The historical rank and industry rank for Iovance Biotherapeutics's Days Inventory or its related term are showing as below:
IOVA'
s Days Inventory Range Over the Past 10 Years
Min: 108.75 Med: 121.13 Max: 3664.84
Current: 111.93
During the past 13 years, Iovance Biotherapeutics's highest Days Inventory was 3664.84. The lowest was 108.75. And the median was 121.13.
IOVA's Days Inventory is ranked better than 68.91% of 640
companies
in the Biotechnology industry
Industry Median: 184.145
vs IOVA: 111.93
Iovance Biotherapeutics's Days Inventory
declined
from Mar. 2025 (125.04) to Mar. 2026 (118.15).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Iovance Biotherapeutics's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.77.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Iovance Biotherapeutics's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.77.
Iovance Biotherapeutics (NAS:IOVA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Iovance Biotherapeutics's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Iovance Biotherapeutics's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Iovance Biotherapeutics Days Inventory Related Terms
Iovance Biotherapeutics Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IOVA vs HRMY, NRIX, ZYME: Days Inventory Comparison
For the Biotechnology subindustry, Iovance Biotherapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Iovance Biotherapeutics Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Iovance Biotherapeutics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Iovance Biotherapeutics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Iovance Biotherapeutics (IOVA) has a Days Inventory of 118.15 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Iovance Biotherapeutics and its competitors. This is near median its historical median of 121.13. Over the past decade, Iovance Biotherapeutics' Days Inventory has ranged from 108.75 to 3,664.84. According to the industry distribution chart, Iovance Biotherapeutics ranks #199 out of 640 companies in the Biotechnology industry, placing it in the top 31.1%.
Is Iovance Biotherapeutics' Days Inventory too high?
Iovance Biotherapeutics' current Days Inventory of 118.15 is near median its 10-year median of 121.13. Over the past 10 years, this metric has ranged from a low of 108.75 to a high of 3,664.84. The Biotechnology industry median Days Inventory is 184.15. Iovance Biotherapeutics' value of 118.15 is 35.8% below this industry median. Based on the distribution chart, Iovance Biotherapeutics ranks #199 out of 640 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Iovance Biotherapeutics has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Iovance Biotherapeutics' Days Inventory compare to HRMY and NRIX?
According to the Biotechnology industry distribution chart, Iovance Biotherapeutics ranks #199 out of 640 companies for Days Inventory. This puts Iovance Biotherapeutics in the upper half of its industry. The industry median Days Inventory is 184.15. Iovance Biotherapeutics' value of 118.15 is 35.8% below this benchmark. Historically, Iovance Biotherapeutics' own Days Inventory has ranged from 108.75 to 3,664.84 over the past decade. While the company's 10-year median is 121.13 vs. the industry median of 184.15, Iovance Biotherapeutics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 184.15, based on 640 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Iovance Biotherapeutics's current Days Inventory of 118.15 is 35.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Iovance Biotherapeutics and its competitors. For the Biotechnology industry, the median Days Inventory is 184.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Iovance Biotherapeutics's current Days Inventory is 118.15, which is near median its own 10-year median of 121.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Iovance Biotherapeutics stock overvalued right now?
Based on GuruFocus' analysis, Iovance Biotherapeutics (IOVA) is currently considered Possible Value Trap. The stock's GF Value™ is $18.84, compared to a current price of $4.23 — trading 77.5% below its estimated fair value. The current Days Inventory is 118.15, which is near median its 10-year median of 121.13 and 35.8% below the Biotechnology industry median of 184.15. Iovance Biotherapeutics' overall GF Score™ is 44/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Iovance Biotherapeutics (IOVA), the current Days Inventory is 118.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Iovance Biotherapeutics (IOVA) Overvalued in 2026?
Based on GuruFocus' analysis, Iovance Biotherapeutics stock appears to be undervalued.
The current stock price of $4.23 is trading 77.5% below its estimated GF Value™ of $18.84.
GuruFocus considers Iovance Biotherapeutics to be Possible Value Trap.
Key valuation signals for IOVA:
Days Inventory: 118.15 (near median its 10-year median of 121.13)
GF Value™: $18.84 vs. price of $4.23 (77.5% below fair value)
Industry Position: 35.8% below the Biotechnology median (#199 of 640)
No single metric tells the full story. See the IOVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
44GF Score
Get the complete analysis for IOVA
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IOVA has been successfully added to your 
